BioStem Technologies, Inc.
BSEMHealthcare|Biotechnology|US
$1.13
+0.09 (+8.65%)
Tangible Book / Share
$0.27
Cash / Share
$0.40
Clinical Trials (4)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT06811909 Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC | Non-infected Venous Leg Ulcer, Venous Leg Ulcer | N/A | Completed | 71 | RCT, Single-blind | — |
| NCT06150209 A Controlled Prospective Treatment Study to Evaluate the Efficacy of Vendaje. | Diabetic Foot Ulcer | N/A | Withdrawn | — | Open-label | — |
| NCT06565156 Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AM | Non-infected Diabetic Foot Ulcer, Diabetic Foot | N/A | Completed | 72 | RCT, Single-blind | — |
| NCT06511596 A Prospective Trial of Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AC | Diabetic Foot Ulcer | N/A | Completed | 71 | RCT, Single-blind | — |